| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Treasury stock purchases for restricted stock vests | 11,598 | 10,554 |
| Payments on contingent consideration | 26 | 0 |
| Payment of accrued licensor payments | 0 | - |
| Net cash and cash equivalents (used in) provided by financing activities | -5,308 | -11,653 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1,120 | 544 |
| Net change in cash, cash equivalents, and restricted cash | 117,752 | 72,939 |
| Cash and cash equivalents at beginning of period | 144,894 | - |
| Cash and cash equivalents at end of period | 262,646 | - |
ANI PHARMACEUTICALS INC (ANIP)
ANI PHARMACEUTICALS INC (ANIP)